1 / 8

PRECONCEPTION COUNSELING AND CARE FOR HIV-INFECTED WOMEN OF CHILDBEARING AGE

PRECONCEPTION COUNSELING AND CARE FOR HIV-INFECTED WOMEN OF CHILDBEARING AGE. Preconception Counseling and Care (1). Preconception care is part of routine primary care and is recommended by the CDC , ACOG, and other national organizations. Purpose: Prevention of unintended pregnancies

Download Presentation

PRECONCEPTION COUNSELING AND CARE FOR HIV-INFECTED WOMEN OF CHILDBEARING AGE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. PRECONCEPTION COUNSELING AND CARE FOR HIV-INFECTED WOMEN OF CHILDBEARING AGE

  2. Preconception Counseling and Care (1) • Preconception care is part of routine primary care and is recommended by the CDC, ACOG, and other national organizations. • Purpose: • Prevention of unintended pregnancies • Optimization of maternal health prior to pregnancy • Prevention of perinatal transmission • Prevention of HIV transmission to an uninfected partner while trying to conceive www.aidsetc.org

  3. Preconception Counseling and Care (2) Recommendations • Discuss childbearing intentions with all women of childbearing age on an ongoing basis throughout the course of their care. (AIII) • Include information about effective and appropriate contraceptive methods. (AI) • Preconception counseling: Include information on safer sex and elimination of alcohol, illicit drugs, and smoking. (AII) www.aidsetc.org

  4. Preconception Counseling and Care (3) • Include assessment of HIV disease status and need for ART for the health of the woman. (AII) • Choose an ART regimen for HIV-infected women of childbearing age based on: • Efficacy • Hepatitis B status • Teratogenic potential • Possible adverse outcomes for mother and fetus(AII) www.aidsetc.org

  5. Reproductive Options for HIV-Concordant and Serodiscordant Couples (1) All couples: • Both partners should be screened for genital tract infections. (AII) • Semen analysis is recommended for HIV-infected men. HIV, and possibly ART, may be associated with a higher prevalence of abnormalities. www.aidsetc.org

  6. Reproductive Options for HIV-Concordant and Serodiscordant Couples (2) Serodiscordant couples: • Expert consultation is recommended. (AIII) • No single method of safer conception is fully protective against transmission of HIV. • Initiation of ART for the HIV-infected partner is recommended (AI for CD4 counts ≤550 cells/µL and BIII for CD4 counts >550 cells/µL). • Maximal viral suppression is recommended before attempting conception. (AIII) • HPTN 052 trial showed ART can significantly decrease HIV transmission to uninfected partners. www.aidsetc.org

  7. Reproductive Options for HIV-Concordant and Serodiscordant Couples (3) • HIV-infected female with uninfected male partner: The safest option is artificial insemination, including the option of self-insemination, during the periovulatory period. (AIII) • HIV-infected man with uninfected female: Sperm preparation techniques + either intrauterine insemination or in vitro fertilization should be considered if using donor sperm from an uninfected male is unacceptable. (AII) www.aidsetc.org

  8. Reproductive Options for HIV-Concordant and Serodiscordant Couples (4) • Periconception administration of PrEP for HIV-uninfected partners may offer an additional tool to reduce the risk of sexual transmission. (CIII) • The utility of PrEP of the uninfected partner when the infected partner is receiving ART has not been studied. • Outcome studies are needed to examine adverse events, including risk of congenital abnormalities. www.aidsetc.org

More Related